EUVIMEDEUVIMED entdecken
Metaanalyse

Efficacy and Safety of Endoscopic Anti-Reflux Therapy versus Sham or Proton Pump Inhibitor Control in Gastro-oesophageal Reflux Disease: A Meta-Analysis of Randomised Controlled Trials

Tiffano Taufan Firdaus, Vesri Yoga

Sriwijaya Journal of Internal Medicine · 31.07.2026 · 4 (2) · 81-88

DOI: 10.59345/sjim.v4i2.296 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Sriwijaya Journal of Internal Medicine, online erschienen am 31.07.2026. Verfasst von Tiffano Taufan Firdaus und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gastro-oesophageal reflux disease (GERD) is among the most prevalent chronic disorders, and lifelong proton pump inhibitor (PPI) dependence is common. Endoscopic anti-reflux therapies are minimally invasive alternatives between medical and surgical management, but individual device trials are small and the randomised evidence has largely been synthesised device by device.

Objective

To pool the randomised evidence across all endoscopic anti-reflux modalities against a common control and provide a single, class-level estimate of benefit in adults with GERD.

Methods

Four databases were searched for randomised controlled trials comparing endoscopic anti-reflux therapy (radiofrequency, suturing/plication, injection/implant, transoral incisionless fundoplication) with a sham procedure and/or continued PPI in adults with GERD. Risk ratios (RR) for treatment success were pooled with a DerSimonian–Laird random-effects model; heterogeneity was quantified with I² and a prediction interval; bias was appraised with Cochrane RoB 2.0.

Results

Twelve trials were eligible; seven were pooled (536 participants; follow-up 3–6 months). Endoscopic anti-reflux therapy approximately doubled treatment success versus sham or PPI control (pooled RR 1.89, 95% CI 1.51–2.37; p

Zitieren

APA

Firdaus, T. T., & Yoga, V. (2026). Efficacy and Safety of Endoscopic Anti-Reflux Therapy versus Sham or Proton Pump Inhibitor Control in Gastro-oesophageal Reflux Disease: A Meta-Analysis of Randomised Controlled Trials. Sriwijaya Journal of Internal Medicine, 4(2), 81-88. https://doi.org/10.59345/sjim.v4i2.296

Vancouver

Firdaus TT, Yoga V. Efficacy and Safety of Endoscopic Anti-Reflux Therapy versus Sham or Proton Pump Inhibitor Control in Gastro-oesophageal Reflux Disease: A Meta-Analysis of Randomised Controlled Trials. Sriwijaya Journal of Internal Medicine. 2026;4(2):81-88. doi:10.59345/sjim.v4i2.296

BibTeX
@article{Firdaus2026,
  author = {Firdaus, Tiffano Taufan and Yoga, Vesri},
  title = {Efficacy and Safety of Endoscopic Anti-Reflux Therapy versus Sham or Proton Pump Inhibitor Control in Gastro-oesophageal Reflux Disease: A Meta-Analysis of Randomised Controlled Trials},
  journal = {Sriwijaya Journal of Internal Medicine},
  year = {2026},
  volume = {4},
  number = {2},
  pages = {81--88},
  doi = {10.59345/sjim.v4i2.296}
}
Kostenlos starten →